Swiss Pharma International AG et al. vs. Biogen MA Inc.
Explore the PTAB proceeding IPR2016-00912 filed by Swiss Pharma International AG et al. on 2016-04-18. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-00912
Filing Date
2016-04-18
Accorded Filing Date
2016-04-18
Institution Decision Date
2016-10-17
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
โ
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Swiss Pharma International AG et al.
Represented By
Lowe, JeremyPatent Owner / Respondent
Biogen MA Inc.
Represented By
Reister, Andreaet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 76845 | Huimin Chen | +1 202-942-6119 |
| 67788 | Nicholas Nyemah | +1 202-942-6681 |
| 76829 | Michael Lewis | +1 202-942-6728 |
| 76738 | Lindsey Staubach | +1 540-818-4689 |
| 82123 | Dennis Keritsis | +1 202-942-6619 |
| 54390 | Brent Ray | +1 312-995-6333 |
| 77536 | Alyson Nickols | +1 650-448-3073 |
| 75595 | Michael Sebba | +1 212-836-7529 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 8,815,236 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 44,581,803 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2005005359 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,349,321 B2 | US Continuation / Sibling | View Official Patent → |
Swiss Pharma International AG et al. v. Biogen MA Inc.